The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade. - sprookjes - yvandenbroek - TriplyDB

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.

http://www.wikidata.org/entity/Q33999756

about

Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models The HIV glycan shield as a target for broadly neutralizing antibodies Recent strategies targeting HIV glycans in vaccine design A Blueprint for HIV Vaccine Discovery Designing synthetic vaccines for HIV Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16 Structural Basis for Enhanced HIV-1 Neutralization by a Dimeric Immunoglobulin G Form of the Glycan-Recognizing Antibody 2G12 Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies Glycans, galectins, and HIV-1 infection Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies Pharmacokinetics of the Antiviral Lectin Griffithsin Administered by Different Routes Indicates Multiple Potential Uses Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein High-throughput profiling of anti-glycan humoral responses to SIV vaccination and challenge Structural plasticity of the Semliki Forest virus glycome upon interspecies transmission.HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.MALDI-MS/MS with traveling wave ion mobility for the structural analysis of N-linked glycans.Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates Synthetic carbohydrate antigens for HIV vaccine design.Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization HIV-1 envelope proteins and V1/V2 domain scaffolds with mannose-5 to improve the magnitude and quality of protective antibody responses to HIV-1 Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection.Glycosylation and disulfide bond analysis of transiently and stably expressed clade C HIV-1 gp140 trimers in 293T cells identifies disulfide heterogeneity present in both proteins and differences in O-linked glycosylation Partial enzymatic deglycosylation preserves the structure of cleaved recombinant HIV-1 envelope glycoprotein trimers.Glycoform and net charge heterogeneity in gp120 immunogens used in HIV vaccine trials.Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012.Prime-boost immunization of rabbits with HIV-1 gp120 elicits potent neutralization activity against a primary viral isolate.Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir HIV-1 envelope glycan moieties modulate HIV-1 transmission.Structural evolution of glycan recognition by a family of potent HIV antibodies.Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope Deletion of the highly conserved N-glycan at Asn260 of HIV-1 gp120 affects folding and lysosomal degradation of gp120, and results in loss of viral infectivity Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate.

P2860

Q24610025-E31A306B-52E7-48CE-BA67-0A3196FDF6F7 Q26786540-FFDEF320-E1C6-4DA4-8B7A-50673AE74D97 Q26823603-5D8A0B80-D76B-440A-82D8-CE0A81291CA1 Q26829865-35C7A66D-D875-48CD-993D-71B442D629C8 Q26862617-D6E087C2-E3BE-4171-B98B-193ADF9AD048 Q27319450-7310488A-1A4E-485A-A275-F4D87DCD77A1 Q27674878-3C7AA062-CB97-4562-A741-57C5DE2FE0C7 Q27678062-8530632E-71F8-4DF7-B34B-F4ED7F2F982E Q27678312-35D58EDC-52C3-4F45-AC22-94DACE08C347 Q27680810-888ADB24-52C0-4BFF-9103-DA87CFEAFEC4 Q28084672-E82B8C7A-0D35-4D5B-8FD7-FA161970712C Q28263063-39656897-3999-4D47-AF32-11D123344A5B Q28263655-3FF741EE-87B3-46FB-BFF0-D43F9E87C560 Q28263932-886E3163-B7E8-44FD-B384-311371F1BD40 Q28265115-751F3535-44A6-4F0C-A226-9F6DB2FB540B Q28271300-AD12FD81-817B-4FE9-A162-0584A964DF5C Q28299280-18069CAB-CD1B-4D7F-9DDA-823CED795978 Q28354743-288C31FC-FECB-4AC5-B0D1-8E4937C2260B Q28485983-202F1940-7CE9-42C7-A99F-B2A0A744E0E5 Q29306052-FB02AA74-B2C8-418B-BFED-EC1DBFE55DAF Q30354064-6667D364-288C-4138-80FD-B691AAEADD05 Q30358358-D3C5ECCC-4F58-4939-9483-94D6AB0F678B Q30393763-E2563A69-FF40-42E9-AABB-E5C6950C2E8B Q31095515-CE3D3101-98DD-4602-B469-40CC4B9C4AE5 Q33612459-AD68E8A5-9A9C-4180-896F-AEC851E79F73 Q33909079-FF2F9B05-660E-452B-A92C-DDFB0D1EE7D0 Q33946158-D91555D9-B9F6-4119-9910-9CD19D519D5C Q33947008-372B3128-2621-434B-978D-6B27F3097FE5 Q34034659-7A0B84D8-F2F7-4E1D-9EA0-43D3DDC51497 Q34141693-928A74E6-89F8-4A3F-BF14-317F463AFBE4 Q34285680-38FC3A32-1009-4C49-A669-532D5F7B15BF Q34396095-1204FA2E-2449-4695-B9D8-784FA5349DCF Q34489424-D3E628E1-2524-4B3E-9363-A3469D97AF40 Q34551010-B468092E-61FE-4DE1-B843-A40C81FAA6D6 Q34583552-7FD18AEE-BAFE-44AF-832D-343BB0F59BE0 Q34595009-A387CACC-9032-4EA5-9600-046B5CE2513A Q34782382-3DD20FDF-E07C-458A-BC5D-8CECF88FD705 Q34991017-9B98534C-C2A7-4E9C-98F5-FA4AB3BA607D Q35195445-A58ED091-9F7A-48AB-B6AB-6C08D94AE999 Q35542138-1025DF9D-F760-417D-9463-7CA1DD974346

P2860

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.

http://www.wikidata.org/entity/Q33999756

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The glycan shield of HIV is pr ...... duction system or viral clade.

@ast

The glycan shield of HIV is pr ...... duction system or viral clade.

@en

type

label

The glycan shield of HIV is pr ...... duction system or viral clade.

@ast

The glycan shield of HIV is pr ...... duction system or viral clade.

@en

prefLabel

The glycan shield of HIV is pr ...... duction system or viral clade.

@ast

The glycan shield of HIV is pr ...... duction system or viral clade.

@en

P1433

Q33999756-B64C16BF-6CF1-4551-9FDC-29B8C1A695BF

P1476

Q33999756-D7B50589-056F-40F5-B34A-FE6143D1EF49

P2093

Q33999756-1CA04198-9F62-4DF7-A2A7-F107BEE37667

Q33999756-49FEBD5D-55DC-4A0F-8A21-CF78D8B901C0

Q33999756-4DB44AF7-12E0-4866-8D09-395A1057A2C8

Q33999756-B4239F10-47B6-4208-9018-C77D1D8C115E

Q33999756-C5F73936-C64D-4D34-B130-89F866CB1A29

Q33999756-FAC67292-B04C-481A-A814-AB354C7CFC6D

P2860

Q33999756-0120A600-1125-402E-86E8-46A4544ECF67

Q33999756-01E4F315-9C24-4F6A-A7CF-78B81608A24E

Q33999756-05E722A3-5B29-4933-8379-1BE0220EA079

Q33999756-0E40712B-C968-460A-8860-C635C0578A1C

Q33999756-1053A239-CB51-46CE-9EF6-D1CB9F7A9377

Q33999756-1213D357-D943-4FB0-BAD9-F243BF1C5001

Q33999756-1893B08B-9A76-4F20-BA31-FA94F0C8691A

Q33999756-1DFBA1B9-EE1D-4C19-900D-7F1B08975D9C

Q33999756-1E8210CE-EC13-46B4-914F-C8463134013F

Q33999756-1ED3729E-5A63-43D1-A318-D8D25C8D53BD

P304

Q33999756-628D81AC-BB5B-47EE-ABF9-5783A462F27E

P31

Q33999756-73D225BC-8A3F-4A6C-B7D1-A9843032EEF4

P356

Q33999756-4B70203B-2AE0-4902-9128-9833C01D36C8

P407

Q33999756-DD48CA97-C72A-45B0-A645-3A35AC46AA50

P433

Q33999756-E8DE6772-94FA-4468-8D0E-0971F3E10D14

P478

Q33999756-B0CFCEB9-E2EC-4155-BC86-CFAC7F56FA4E

P50

Q33999756-AC41DE6F-5780-459E-98A7-117B28BA24D4

Q33999756-B7999B13-9F69-44FE-BE2E-705CA5D8ED69

P577

Q33999756-8E0FBD96-38BB-4C35-8CA5-3C4896B1F203

P5875

Q33999756-7DA7CE08-887C-4EBE-B925-327FDEF85F33

P698

Q33999756-C8DA42D2-9D31-489C-87CF-07221CE87A3A

P932

Q33999756-33DBD195-70ED-4DB0-92D4-CFF499CC73FB

P356

JOURNAL.PONE.0023521

P1433

P1476

The glycan shield of HIV is pr ...... oduction system or viral clade

@en

P2093

Camille Bonomelli

http://www.w3.org/2001/XMLSchema#string

Christopher N Scanlan

http://www.w3.org/2001/XMLSchema#string

D Cameron Dunlop

http://www.w3.org/2001/XMLSchema#string

Dennis R Burton

http://www.w3.org/2001/XMLSchema#string

Raymond A Dwek

http://www.w3.org/2001/XMLSchema#string

Victoria Thaney

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

Crystal Structure and Carbohydrate Analysis of Nipah Virus Attachment Glycoprotein: a Template for Antiviral and Vaccine Design

A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity

Assembly of asparagine-linked oligosaccharides

GP120: target for neutralizing HIV-1 antibodies

Antibody neutralization and escape by HIV-1

A time- and cost-efficient system for high-level protein production in mammalian cells

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies

Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells.

P304

e23521

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0023521

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51586960

http://www.w3.org/2001/XMLSchema#string

P698

21858152

http://www.w3.org/2001/XMLSchema#string

P932

3156772

http://www.w3.org/2001/XMLSchema#string